Cancer-related fatigue.
Conditions
Interventions
Intervention 1: Intervention group: Fluoxetine 20 mg/d (Exir pharmaceutics, Iran) for the first 5 days then twice a day for the rest of the first month. In the second month, depending on the patient's
Sponsors
Shahre-kord University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Definite diagnosis of cancer from at least 2 month ago Patients are undergoing outpatient chemotherapy Lack of metastasis Lack of any chronic cardiac or respiratory diseases or diabetes mellitus Lack of severe bone pain and balance problem Hemoglobin= 10 Ability to read and write Not receiving any type of treatment (drug or psychotherapy) for fatigue in the past Not having leukemia Lack of past history of any major psychiatric illnesses for which patient was hospitalized or medicated
Exclusion criteria
Exclusion criteria: Acute respiratory, cardiac or infectious diseases Hemoglobin<10 Uncontrolled hypothyroidism
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fatigue score in Cancer Fatigue scale and Fatigue Visual Analogue scale. Timepoint: Before intervention, 1 month and 2 months after pharmacotherapy. Method of measurement: Cancer Fatigue scale, Fatigue Visual Analogue scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| The Quality of life score in European Organization for Research and treatment of cancer quality of life questionnaire. Timepoint: Before intervention, 1 month and 2 months after pharmacotherapy. Method of measurement: European Organization for Research and treatment of cancer quality of life questionnaire version 3. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactElham Zarean
Shahre-kord University of Medical Sciences
Outcome results
None listed